Could a common steroid boost stroke recovery?

NCT ID NCT07175649

Not yet recruiting Disease control Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study tests whether adding the steroid methylprednisolone to standard clot-removal treatment helps people recover from severe stroke. About 912 adults aged 18–85 with a large clot in the front part of the brain will receive either the steroid or a placebo for three days. The goal is to see if more people can live independently 90 days later.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Methylprednisolone (a steroid anti-inflammatory drug)
What this could lead to: If it works, this could show that adding a steroid to standard clot removal improves recovery for people with severe stroke.
What could go wrong: This is an early-stage trial with no phase assigned, so results are uncertain. Steroids can have side effects like infection risk, and the benefit may be small or absent.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE DUE TO ANTERIOR CIRCULATION LARGE VESSEL OCCLUSION WITH LARGE INFARCT CORE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

ischemic stroke large artery stroke

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ISCHEMIC STROKE, ACUTE

Contacts and locations

Locations

Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University

Guangzhou, Guangdong, 510120, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.